| SnapShot: COVID-19 B Oberfeld, A Achanta, K Carpenter, P Chen, NM Gilette, P Langat, ... Cell 181 (4), 954-954. e1, 2020 | 143 | 2020 |
| Building a Tool Kit for Medical and Dental Students: Addressing Microaggressions and Discrimination on the Wards R Sandoval, T Afolabi, J Said, S Dunleavy, A Chatterjee, D Ölveczky MedEdPORTAL, 2020 | 70 | 2020 |
| Student-Led Efforts to Advance Anti-Racist Medical Education T Afolabi, HM Borowsky, DM Cordero, DW Paul, JT Said, RS Sandoval, ... Academic Medicine 96 (6), 802-807, 2021 | 46 | 2021 |
| Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer LL Thompson, NA Krasnow, MS Chang, J Yoon, EB Li, NJ Polyakov, ... JAMA Dermatology 157 (5), 577-582, 2021 | 39 | 2021 |
| Remote Medical Education: Adapting Kern’s Curriculum Design to Tele-teaching JT Said, AW Schwartz Medical Science Educator 31 (2), 805-812, 2021 | 32 | 2021 |
| 3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators M McAvoy, ATN Bui, C Hansen, D Plana, JT Said, Z Yu, H Yang, J Freake, ... BMC Biomedical Engineering 3 (1), 1-14, 2021 | 30 | 2021 |
| Equity in medical education: Addressing microaggressions and discrimination on the wards RS Sandoval, S Dunleavy, T Afolabi, JT Said, J Connor, A Hossain, ... Medical Teacher 44 (5), 551-558, 2022 | 22 | 2022 |
| Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity LL Thompson, EB Li, NA Krasnow, MS Chang, JT Said, GE Molina, ... British Journal of Dermatology 185 (3), 627-635, 2021 | 15 | 2021 |
| Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors JT Said, M Liu, J Talia, SB Singer, YR Semenov, EX Wei, A Mostaghimi, ... JAMA Dermatology, 2022 | 14 | 2022 |
| Treatment of immune checkpoint inhibitor–mediated psoriasis: A systematic review JT Said, SA Elman, LM Perez-Chada, C Mita, JF Merola, NR LeBoeuf Journal of the American Academy of Dermatology 87 (2), 399-400, 2022 | 12 | 2022 |
| Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor–induced bullous pemphigoid JT Said, J Talia, E Wei, A Mostaghimi, Y Semenov, A Giobbie-Hurder, ... Journal of the American Academy of Dermatology 88 (3), 670-671, 2023 | 11 | 2023 |
| Disseminated varicella-zoster virus infections following messenger RNA–based COVID-19 vaccination JT Said, CA Virgen, CG Lian, CS Cutler, JF Merola, NR LeBoeuf JAAD Case Reports 17, 126-129, 2021 | 11 | 2021 |
| Association between halo nevi and melanoma in adults: A multicenter retrospective case series D Haynes, JL Strunck, J Said, I Tam, A Varedi, CA Topham, B Olamiju, ... Journal of the American Academy of Dermatology 84 (4), 1164-1166, 2021 | 9 | 2021 |
| Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors LL Thompson, MS Chang, NJ Polyakov, AE Blum, N Josephs, ... Journal of the American Academy of Dermatology 86 (4), 886-889, 2022 | 8 | 2022 |
| Use of an educational video to improve transgender health care knowledge CE Guss, S Dahlberg, JT Said, J Addison, SL Katz-Wise Clinical Pediatrics 61 (5-6), 412-417, 2022 | 7 | 2022 |
| Prevalence of inverse psoriasis subtype with immune checkpoint inhibitors A Jfri, B Leung, JT Said, Y Semenov, NR LeBoeuf Immunotherapy Advances 2 (1), ltac016, 2022 | 7 | 2022 |
| Impact of a case-based collaborative learning curriculum on knowledge and learning preferences of dermatology residents JT Said, LL Thompson, L Foord, ST Chen International Journal of Women's Dermatology 6 (5), 404-408, 2020 | 7 | 2020 |
| Medical student perceptions of assessment systems, subjectivity, and variability on introductory dermatology clerkships J Yoon, JT Said, LL Thompson, GE Molina, JB Richards, ST Chen International Journal of Women's Dermatology 7 (3), 323-330, 2021 | 6 | 2021 |
| Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer … IR Plumptre, JT Said, T Sun, C Larocca, CA Virgen, TS Kupper, DC Fisher, ... Leukemia & Lymphoma 63 (12), 2832-2846, 2022 | 4 | 2022 |
| Evaluating safety and compatibility of anti-tumor necrosis factor therapy in patients with connective tissue disorders JT Said, SA Elman, JF Merola Annals of Translational Medicine 9 (5), 2021 | 4 | 2021 |
